Oxycodone: New opioid in Spain;Oxicodona: nuevo opioide en España

Clinical and Translational Oncology

Volumn 6, Issue 4, 2004, Pages 203-206

  Ordóñez Gallego, Amalio ^a   González Barón, Manuel ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Opioid; Oxycodone; Pain

Indexed keywords

EID: 33644780632     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/bf02711723     Document Type: Review

References (37)

1. Ordóñez A, González Barón M, Feliu J, et al. Tratamiento de soporte en el enfermo con cáncer. Algunas propuestas basadas en nuestra experiencia. Rev Oncol 2001;3:266-9.
2. Ordóñez A, de Castro J, Espinosa E, et al. Transdermal fentanyl treatment in opioid-naïve cancer patients. Rev Oncol 2003;5:162-5.
3. Mercadante S. Is morphine the drug of choice in cancer pain? Progress in Palliative Care 2001;9:5.
4. Falk E. Eukodal, ein neues narkotikum. Muenchener Medizinische Wochenschrift, 1917; 20: 381-4.
5. Poyhia R, Vainio A, Kalso E. A review of oxycodonés clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage 1993;8:63-7.
6. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990;47:639-46.
7. Leow KP, Cramond T, Smith MY. Pharmacokinetics and pharmaco-dynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain. Anesth Analg 1995;80:296-302.
8. Levy MH. Advancement of opioid analgesia with controlled- release oxycodone. Europ J Pain 2001:5 (Suppl A):113-6.
9. Evans PJD. Controlled-release oxycodone: Do we need another opiate analgesic? Europ J Pain 1999;3:67-8.
10. Shah S, Hardy J. Oxycodone: a review of the literature. Eur J Palliative Care 2001;8:93-6.
11. Cairns R. The use of oxycodone in cancer-related pain: a literature review. Intern J Palliative Nursing 2001;7: 522-7.
12. Inturrisi ChE. Clinical pharmacology of opioids for pain. The Clinical J of Pain 2002; 18: S3-13.
13. Makin MK. Strong opioids for cancer pain. J Royal Soc Med 2001;94:17-21.
14. Rischitelli G, Karbowicz SH. Safety and efficacy of controlled- release oxycodone: a systematic literature review. Pharmacotherapy 2002;22(7):898-904.
15. Colucci RD, Swanton RE, Gordon ThB, Kaiko RF. Relative variability in bioavailability of oral controlled-release formulations of oxycodone and morphina. Am J Therapeutics 2001;8:231-6.
16. Leow KP, Smoith MT, Williams B. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer. Clin Pharmacol Ther 1992;52:487-95.
17. Benziger DP, Cheng C, Miotto J, et al. Comparative pharmacokinetics of controlled release oxycodone (Oxycontin) in special populations. Proc Eighth World Congress on Pain; 1996 Aug 17-22; Vancouver.
18. Kaiko RF, Benzinger DP, Fitzmartin RD, et al. Pharmacokinetic- pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 1996;59:52-61.
19. Heiskanen T, Olkkola KT, Kalso E. Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacol Ther 1998;64:603-11.
20. Poyhia R, Seppala T, Olkkola KT, Kalso E. The pharmacokinetics and metabolism of oxycodone alter intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol 1992;33:617-21.
21. Davis M, Wilcock A. Modified-release opioids. Eur J Palliative Care 2001;8(4):142-6.
22. Mandema JW, Kaiko RF, Oshlack B, et al. Pharmacokinetic model for a new oral controlled release formulation of oxycodone [abstract]. Anesthesiology 1994;81:1.
23. Curtis GB, Johnson GH, Clark P, et al. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 1999;55:425-9.
24. Hagen N, Babul N. Comparative clinical efficacy and safety of a novel controlled release oxycodone formulation and controlled release hydromorphone in the treatment of cancer pain. Cancer 1997;79:1428-37.
25. Heiskanen T, Kalso E. Controlled-release oxycodone and morphine in cancer related pain. Pain 1997;73:37-45.
26. Citron M, Kaplan R, Parris W, et al. Long-term administration of controlled release oxycodone tablets for the treatment of cancer pain. Cancer Invest 1998;16:562-71.
27. Mucci-LeRusso P, Berman BS, Silberstein PT, et al. Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double blind, parallel-group study. Eur J Pain 1998;2:239-49.
28. Bruera E, Belzile M, Pituskin E. Randomised, double blind cross over trial comparing safety and efficacy of oral controlled release oxycodone with controlled release morphine in patients with cancer pain. J Clin Oncol 1998;16(10):3222-9.
29. Kaplan R, Parris W, Citron M, et al. Comparison of controlled release and immediate release oxycodone tablets in patients with cancer pain. J Clin Oncol 1998;16: 3230-7.
30. Parris W, Johnson B, Croghan M, et al. The use of controlled release oxycodone for the treatment of chronic cancer pain: a randomised, double-blind study. J Pain Symptom Manage 1998;16:205-11.
31. Salzman R, Roberts M, Wild J, et al. Can a controlled release oral dose form of oxycodone be used as readily as an immediate release form for the purpose of titrating to stable pain control? J Pain Symptom Manage 1999; 18(4):271-9.
32. Stambaugh JE, Reder RF. Double-blind, randomized comparison of the analgesic and pharmacokinetic profiles of controlled- and immediate- release oral oxycodone in cancer pain patients. J Clin Pharmacol 2001;41: 500-6.
33. Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be k-opioid receptor mediated. Pain 1997;73:151-7.
34. Maddocks I, Somogyi A, Abbott F, et al. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 1996;12:182-9.
35. Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids: A critical review and proposals for long-term doping. J Pain Symptom Manage 2001;22:672-87.
36. Ripamonti C, Dickerson ED. Strategies for the treatment of cancer pain in the new millennium. Drugs 2001; 61(7):955-77.
37. Patt RB. Using controlled-release oxycodone for the management of chronic cancer and noncancer pain. Am Pain Soc Bulletin 1996;6:1-6.